Otonomy OTIC

Quarterly report 2022-Q3
added 11-10-2022

Otonomy DIO Ratio 2011-2026 | OTIC

Annual DIO Ratio Otonomy

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112	69.7	-	-	0.707	315	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
315	0.707	124

Quarterly DIO Ratio Otonomy

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	148	135	-	-	-	102	-	-	-	-	-	-	-	1.01	-	382	275	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
382	1.01	174

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	Alnylam Pharmaceuticals ALNY	43.5	$ 330.55	-0.85 %	$ 43.3 B	USA
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Amphastar Pharmaceuticals AMPH	166	$ 21.68	-	$ 1.01 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Akebia Therapeutics AKBA	147	$ 1.5	-3.23 %	$ 386 M	USA
	Aquestive Therapeutics AQST	120	$ 4.24	-0.12 %	$ 453 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 24.54	-0.18 %	$ 3.12 B	USA
	BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
	Autolus Therapeutics plc AUTL	70.7	$ 1.48	-1.01 %	$ 394 M	Britain
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Caladrius Biosciences CLBS	35.8	-	-16.75 %	$ 25.8 M	USA
	bluebird bio BLUE	125	-	-	$ 546 M	USA
	AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain